Exercise Intervention in Women With Metastatic Breast Cancer
Pilot Study of a Moderate-Intensity Exercise Intervention in Women With Metastatic Breast Cancer
1 other identifier
interventional
101
1 country
2
Brief Summary
This study is being done to evaluate the impact of moderate-intensity exercise (such as walking) on quality of life, energy level, endurance and mood in women with metastatic breast cancer. Studies have shown that women with early stage breast cancer who exercise during treatment have more energy, less sleep disturbance, less anxiety and depression, and better strength and endurance than women who do not exercise. These studies have also shown that women who exercised during treatment for early stage breast cancer did not develop injuries or increased fatigue from exercising during chemotherapy and radiation treatments. The investigators are conducting this trial to see if women with metastatic breast cancer experience similar benefits from exercise as women with earlier breast cancer. The investigators also wish to determine whether women with advanced disease are able to exercise safely during their treatment under the supervision of an exercise physiologist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Aug 2006
Longer than P75 for not_applicable breast-cancer
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 28, 2006
CompletedFirst Posted
Study publicly available on registry
November 30, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedJune 27, 2016
June 1, 2016
8 years
November 28, 2006
June 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine the impact of a 16 week exercise intervention on physical functioning and cardiorespiratory fitness in a group of patients with metastatic breast cancer.
16 weeks
Secondary Outcomes (2)
To determine the impact of a 16-week exercise intervention on quality of life, fatigue and mood in a group of patients with metastatic breast cancer
16 weeks
To test the feasibility of an exploratory measure of health care utilization in a population of patients with metastatic breast cancer and potential impact on a 16-week exercise intervention on health care utilization.
16 weeks
Study Arms (2)
Immediate Exercise Group
ACTIVE COMPARATORExercise Intervention begins immediately
Delayed Exercise Group
ACTIVE COMPARATORExercise intervention delayed by 16 weeks
Interventions
Exercise program designed by exercise physiologist
Eligibility Criteria
You may qualify if:
- Metastatic or locally advanced breast cancer not amenable to curative surgery
- Life expectance of greater than 12 months
- English speaking
- Pre- and postmenopausal
- Performance status 0-1
You may not qualify if:
- Baseline exercise of more than 150 minutes/week
- Active brain metastases
- Uncontrolled cardiac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dana-Farber Cancer Institutelead
- Beth Israel Deaconess Medical Centercollaborator
Study Sites (2)
Beth Isreal Deaconess Medical Center
Boston, Massachusetts, 02115, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Ligibel, MD
Dana-Farber Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 28, 2006
First Posted
November 30, 2006
Study Start
August 1, 2006
Primary Completion
August 1, 2014
Study Completion
April 1, 2016
Last Updated
June 27, 2016
Record last verified: 2016-06
Data Sharing
- IPD Sharing
- Will not share